Ceftibuten Dihydrate Patent Expiration
Ceftibuten Dihydrate is Used for treating respiratory infections caused by susceptible microorganisms in adults aged 18 and older. It was first introduced by Si Pharmaceuticals Llc
Ceftibuten Dihydrate Patents
Given below is the list of patents protecting Ceftibuten Dihydrate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Cedax | US5599557 | Stable hydrated cephalosporin dry powder for oral suspension formulation |
Feb 04, 2014
(Expired) | Si Pharms |
| Cedax | US5599557 | Stable hydrated cephalosporin dry powder for oral suspension formulation |
Apr 30, 2013
(Expired) | Si Pharms |
Ceftibuten Dihydrate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List